TMCnet News

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Teva Pharmaceutical Industries Limited of Upcoming Deadline
[February 07, 2014]

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Teva Pharmaceutical Industries Limited of Upcoming Deadline


WILMINGTON, Del. --(Business Wire)--

Rigrodsky & Long, P.A.:

  • Do you, or did you, own shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA)?
  • Did you purchase your shares between January 1, 2012 and October 29, 2013, inclusive?
  • Did you lose money in your investment in Teva Pharmaceutical Industries Limited?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A., including former Special Assistant United States Attorney, Timothy J. MacFall, reminds shareholders of Teva Pharmaceutical Industries Limited ("Teva" or the "Company") (NYSE: TEVA) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

A complaint was filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the securities of Teva between January 1, 2012 and October 29, 2013, inclusive (the "Class Period"), alleging violations of the Securities Exchange Act of 1934 against certain of the Company's officers (the "Complaint"). If you wish to serve as lead plaintiff, you must move the Court no later than February 24, 2014.



If you purchased shares of Teva during the Class Period, or purchased shares prior to the Class Period and still hold Teva, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, NY at (888) 969-4242, by e-mail to [email protected], or at: http://www.rigrodskylong.com/news/teva-pharmaceutical-industries-limited-teva.

A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.


Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.


[ Back To TMCnet.com's Homepage ]